Resistance to influenza A virus infection by antigen-conjugated CpG oligonucleotides, a novel antigen-specific immunomodulator

被引:12
作者
Hayashi, M
Satou, E
Ueki, R
Yano, M
Miyano-Kurosaki, N
Fujii, M
Takaku, H
机构
[1] Chiba Inst Technol, Fac Engn, Dept Life & Environm Sci, Narashino, Chiba 2750016, Japan
[2] Chiba Inst Technol, High Technol Res Ctr, Narashino, Chiba 2750016, Japan
[3] Kinki Univ, Kyushu Sch Engn, Dept Chem, Iizuka, Fukuoka 8208555, Japan
基金
日本学术振兴会;
关键词
oligonucleotides; antigen-conjugated oligonucleotides; immunostimulatory sequences; influenza virus; hemagglutinin Th1;
D O I
10.1016/j.bbrc.2005.01.116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oligodeoxynucleotides (ODN) containing CpG motifs (CpG) act as modulators that bias the immune response towards a Th1-dominant phenotype. To investigate this effect further, we examined the protective effects of a covalently linked conjugate between CpG-ODN and HA-2kd antigen in mice infected with influenza A virus. The conjugated form of CpG-ODN and HA-2kd was more efficient in regulating influenza A virus than the unconjugated mixture of CpG-ODN and HA-2kd. The antigen-conjugated CpG-ODN induced an immune response with a Th1-dominant cytokine pattern characterized by the secretion of high levels of HA-2kd-specific interferon-gamma and IgG2a (Th1), which were only slightly induced by HA-2kd alone. These findings support the use of CpG-ODN-Ag conjugates as novel Ag-specific immunomodulators and suggest that CpG-ODN-HA-2kd might be a promising immune therapy for patients with influenza virus. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 34 条
[11]   Mucosal adjuvanticity of immunostimulatory DNA sequences [J].
Horner, AA ;
Cinman, N ;
Ronaghy, A ;
Raz, E .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2000, 22 (1-2) :133-146
[12]   NK- and CD8+ T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides [J].
Kawarada, Y ;
Ganss, R ;
Garbi, N ;
Sacher, T ;
Arnold, B ;
Hämmerling, GJ .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :5247-5253
[13]   CPG MOTIFS IN BACTERIAL-DNA TRIGGER DIRECT B-CELL ACTIVATION [J].
KRIEG, AM ;
YI, AK ;
MATSON, S ;
WALDSCHMIDT, TJ ;
BISHOP, GA ;
TEASDALE, R ;
KORETZKY, GA ;
KLINMAN, DM .
NATURE, 1995, 374 (6522) :546-549
[14]  
Krieg AM, 2001, CURR OPIN MOL THER, V3, P15
[15]   Now I know my CpGs [J].
Krieg, AM .
TRENDS IN MICROBIOLOGY, 2001, 9 (06) :249-252
[16]   Immune effects and mechanisms of action of CpG motifs [J].
Krieg, AM .
VACCINE, 2000, 19 (06) :618-622
[17]   Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response [J].
Lewis, PJ ;
Littel-van den Hurk, SV ;
Babiuk, LA .
JOURNAL OF VIROLOGY, 1999, 73 (12) :10214-10223
[18]   CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-Transgenic mice [J].
Malanchère-Brès, E ;
Payette, PJ ;
Mancini, M ;
Tiollais, P ;
Davis, HL ;
Michel, ML .
JOURNAL OF VIROLOGY, 2001, 75 (14) :6482-6491
[19]   CpG DNA as mucosal adjuvant [J].
McCluskie, MJ ;
Davis, HL .
VACCINE, 1999, 18 (3-4) :231-237
[20]  
MESSINA JP, 1991, J IMMUNOL, V147, P1759